Rhodamine 6G perchlorate structure
|
Common Name | Rhodamine 6G perchlorate | ||
---|---|---|---|---|
CAS Number | 13161-28-9 | Molecular Weight | 543.00800 | |
Density | 1.1631 (rough estimate) | Boiling Point | 603.1ºC at 760mmHg | |
Molecular Formula | C28H31ClN2O7 | Melting Point | 263-265ºC | |
MSDS | Chinese USA | Flash Point | 318.6ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of Rhodamine 6G perchlorateRhodamine 6G perchlorate is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
Name | Rhodamine 6G perchlorate |
---|---|
Synonym | More Synonyms |
Description | Rhodamine 6G perchlorate is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
---|---|
Related Catalog |
Density | 1.1631 (rough estimate) |
---|---|
Boiling Point | 603.1ºC at 760mmHg |
Melting Point | 263-265ºC |
Molecular Formula | C28H31ClN2O7 |
Molecular Weight | 543.00800 |
Flash Point | 318.6ºC |
Exact Mass | 542.18200 |
PSA | 135.27000 |
LogP | 6.57980 |
Appearance of Characters | Crystalline Powder To Crystals | Pink-redto red |
Vapour Pressure | 1.68E-14mmHg at 25°C |
Index of Refraction | 1.6000 (estimate) |
Synonym: Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: None Listed. Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
Not available. Potential Health Effects Eye: May cause eye irritation. Skin: May cause skin irritation. Ingestion: May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated. Inhalation: The toxicological properties of this substance have not been fully investigated. Causes irritation of the mucous membrane and upper respiratory tract. Chronic: No information found. Section 4 - FIRST AID MEASURES Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately. Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Ingestion: Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Notes to Physician: Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Extinguishing Media: Use water spray, dry chemical, carbon dioxide, or appropriate foam. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Wash area with soap and water. Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up, then place into a suitable container for disposal. Avoid generating dusty conditions. Provide ventilation. Section 7 - HANDLING and STORAGE Handling: Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Storage: Store in a tightly closed container. Store in a cool, dry area away from incompatible substances. Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 13161-28-9: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Powder Color: red-pink Odor: none reported pH: Not available. Vapor Pressure: Not available. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: 252 deg C Autoignition Temperature: Not applicable. Flash Point: Not applicable. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Not available. Solubility in water: Not available. Specific Gravity/Density: Not available. Molecular Formula: C28H31ClN2O7 Molecular Weight: 542.67 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Stable under normal temperatures and pressures. Conditions to Avoid: Incompatible materials, strong oxidants. Incompatibilities with Other Materials: Strong oxidizing agents. Hazardous Decomposition Products: Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide. Hazardous Polymerization: Has not been reported Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 13161-28-9 unlisted. LD50/LC50: Not available. Carcinogenicity: Xanthylium,9-2-(ethoxycarbonyl)phenyl-3,6-bis(ethylamino)-,7 - Not listed by ACGIH, IARC, or NTP. Section 12 - ECOLOGICAL INFORMATION Other No information available. Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA Not regulated as a hazardous material. IMO Not regulated as a hazardous material. RID/ADR Not regulated as a hazardous material. Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: Not available. Risk Phrases: Safety Phrases: S 24/25 Avoid contact with skin and eyes. WGK (Water Danger/Protection) CAS# 13161-28-9: No information available. Canada CAS# 13161-28-9 is listed on Canada's NDSL List. CAS# 13161-28-9 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 13161-28-9 is listed on the TSCA inventory. SECTION 16 - ADDITIONAL INFORMATION N/A |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn: Harmful;Xi: Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | 37/39-26-36 |
RIDADR | NONH for all modes of transport |
The fungicide fludioxonil antagonizes fluconazole activity in the human fungal pathogen Candida albicans.
J. Med. Microbiol. 61(Pt 12) , 1696-703, (2012) The fungicide fludioxonil is widely used in agriculture. Residua of this fungicide are occasionally detected in fruits and can therefore be ingested by humans. The human fungal pathogen Candida albica... |
|
Diffusion of ions in a calcium alginate hydrogel-structure is the primary factor controlling diffusion.
Carbohydr. Polym. 94(1) , 82-7, (2013) The diffusion of solutes has been evaluated in an alginate hydrogel as a function of its structure. The role of solute and gel charge on the diffusion measurements were of particular interest. Diffusi... |
|
A novel ionic liquid-in-oil microemulsion composed of biologically acceptable components: an excitation wavelength dependent fluorescence resonance energy transfer study.
J. Phys. Chem. B 117(11) , 3221-31, (2013) In this work we have reported the formulation of a novel ionic liquid-in-oil (IL/O) microemulsion where the polar core of the ionic liquid, 1-ethyl-3-methylimidazolium n-butylsulfate ([C2mim][C4SO4]),... |
EINECS 236-099-4 |
RHODAMINE 6G PERCHLORATE |
[9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium,perchlorate |
MFCD00013117 |